###begin article-title 0
###xml 19 23 19 23 <italic>AFF3</italic>
###xml 33 41 33 41 <italic>IL2/IL21</italic>
Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis
###end article-title 0
###begin p 1
Members of CAPS, the UKRAG Consortium and BSPAR Study Group are listed in the Appendix.
###end p 1
###begin p 2
This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Licence. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
###end p 2
###begin p 3
###xml 299 305 299 305 <italic>PTPN22</italic>
###xml 310 315 310 315 <italic>IL2RA</italic>
###xml 539 543 539 543 <italic>AFF3</italic>
###xml 545 553 545 553 <italic>IL2/IL21</italic>
###xml 555 559 555 559 <italic>IL7R</italic>
###xml 561 566 561 566 <italic>CTLA4</italic>
###xml 571 576 571 576 <italic>CD226</italic>
###xml 794 798 794 798 <italic>AFF3</italic>
###xml 807 815 807 815 <italic>IL2/IL21</italic>
###xml 887 892 887 892 <italic>CTLA4</italic>
###xml 897 901 897 901 <italic>IL7R</italic>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
Recent genetic studies have led to identification of numerous loci that are associated with susceptibility to autoimmune diseases. The strategy of using information from these studies has facilitated the identification of novel juvenile idiopathic arthritis (JIA) susceptibility loci, specifically, PTPN22 and IL2RA. Several novel autoimmune susceptibility loci have recently been identified, and we hypothesise that single-nucleotide polymorphisms (SNPs) within these genes may also be JIA susceptibility loci. Five SNPs within the genes AFF3, IL2/IL21, IL7R, CTLA4 and CD226, previously associated with multiple autoimmune diseases were genotyped, in a large data set of Caucasian JIA patients and controls, and tested for association with JIA. We identified two susceptibility loci for JIA, AFF3 and the IL2/IL21 region and additional weak evidence supporting an association with the CTLA4 and IL7R genes, which warrant further investigation. All results require validation in independent JIA data sets. Further characterisation of the specific causal variants will be required before functional studies can be performed.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 257 258 257 258 <xref ref-type="other" rid="bib1">1</xref>
###xml 260 261 260 261 <xref ref-type="other" rid="bib2">2</xref>
###xml 257 261 257 261 <sup><xref ref-type="other" rid="bib1">1</xref>, <xref ref-type="other" rid="bib2">2</xref></sup>
###xml 650 651 650 651 <xref ref-type="other" rid="bib3">3</xref>
###xml 650 651 650 651 <sup><xref ref-type="other" rid="bib3">3</xref></sup>
Autoimmune diseases are caused by dysregulation of the immune system leading to an immune response to self-tissue. Autoimmune diseases are complex genetic diseases and in the last few years great progress has been made in the search for susceptibility loci.1, 2 As more confirmed autoimmune disease susceptibility loci are identified, an interesting story is emerging in that many of these loci predispose to more than one autoimmune disease. This confirms the hypothesis that shared alleles contribute to a spectrum of diseases and suggests that common immunological pathways are involved in susceptibility to these phenotypically distinct diseases.3
###end p 5
###begin p 6
###xml 315 316 315 316 <xref ref-type="other" rid="bib4">4</xref>
###xml 315 316 315 316 <sup><xref ref-type="other" rid="bib4">4</xref></sup>
###xml 562 568 562 568 <italic>PTPN22</italic>
###xml 568 569 568 569 <xref ref-type="other" rid="bib5">5</xref>
###xml 568 569 568 569 <sup><xref ref-type="other" rid="bib5">5</xref></sup>
###xml 574 579 574 579 <italic>IL2RA</italic>
###xml 579 580 579 580 <xref ref-type="other" rid="bib6">6</xref>
###xml 579 580 579 580 <sup><xref ref-type="other" rid="bib6">6</xref></sup>
###xml 687 688 687 688 <xref ref-type="other" rid="bib5">5</xref>
###xml 690 691 690 691 <xref ref-type="other" rid="bib7">7</xref>
###xml 687 691 687 691 <sup><xref ref-type="other" rid="bib5">5</xref>, <xref ref-type="other" rid="bib7">7</xref></sup>
###xml 713 714 713 714 <xref ref-type="other" rid="bib7">7</xref>
###xml 716 717 716 717 <xref ref-type="other" rid="bib8">8</xref>
###xml 713 717 713 717 <sup><xref ref-type="other" rid="bib7">7</xref>, <xref ref-type="other" rid="bib8">8</xref></sup>
###xml 738 739 738 739 <xref ref-type="other" rid="bib9">9</xref>
###xml 741 743 741 743 <xref ref-type="other" rid="bib10">10</xref>
###xml 738 743 738 743 <sup><xref ref-type="other" rid="bib9">9</xref>, <xref ref-type="other" rid="bib10">10</xref></sup>
###xml 900 908 900 908 <italic>TRAF1/C5</italic>
###xml 913 918 913 918 <italic>STAT4</italic>
###xml 944 946 944 946 <xref ref-type="other" rid="bib11">11</xref>
###xml 944 946 944 946 <sup><xref ref-type="other" rid="bib11">11</xref></sup>
###xml 131 139 <span type="species:ncbi:9606">children</span>
Juvenile idiopathic arthritis (JIA) is another complex genetic autoimmune disease characterised by chronic inflammatory disease in children. It is a group of heterogeneous disorders but encompasses all forms of arthritis of unknown aetiology that starts before the age of 16 and which persists for at least 6 weeks.4 The strategy of using information from autoimmune disease genome-wide association studies or candidate gene studies have facilitated the search for novel JIA susceptibility loci. Indeed two recently identified confirmed JIA susceptibility loci, PTPN225 and IL2RA6 are putative autoimmune susceptibility genes as they also show association with rheumatoid arthritis (RA),5, 7 type I diabetes (T1D)7, 8 and Graves' disease.9, 10 In addition, using a strategy of examining confirmed RA susceptibility loci in JIA, we have recently reported evidence for association of two further loci (TRAF1/C5 and STAT4) with JIA susceptibility.11
###end p 6
###begin p 7
###xml 186 188 186 188 <xref ref-type="other" rid="bib12">12</xref>
###xml 190 192 190 192 <xref ref-type="other" rid="bib13">13</xref>
###xml 186 192 186 192 <sup><xref ref-type="other" rid="bib12">12</xref>, <xref ref-type="other" rid="bib13">13</xref></sup>
###xml 216 220 216 220 <italic>IL7R</italic>
###xml 221 223 221 223 <xref ref-type="other" rid="bib14">14</xref>
###xml 225 227 225 227 <xref ref-type="other" rid="bib15">15</xref>
###xml 229 231 229 231 <xref ref-type="other" rid="bib16">16</xref>
###xml 221 231 221 231 <sup><xref ref-type="other" rid="bib14">14</xref>, <xref ref-type="other" rid="bib15">15</xref>, <xref ref-type="other" rid="bib16">16</xref></sup>
###xml 231 236 231 236 <italic>CTLA4</italic>
###xml 237 239 237 239 <xref ref-type="other" rid="bib17">17</xref>
###xml 237 239 237 239 <sup><xref ref-type="other" rid="bib17">17</xref></sup>
###xml 239 243 239 243 <italic>AFF3</italic>
###xml 243 245 243 245 <xref ref-type="other" rid="bib14">14</xref>
###xml 243 245 243 245 <sup><xref ref-type="other" rid="bib14">14</xref></sup>
###xml 250 255 250 255 <italic>CD226</italic>
###xml 256 258 256 258 <xref ref-type="other" rid="bib18">18</xref>
###xml 256 258 256 258 <sup><xref ref-type="other" rid="bib18">18</xref></sup>
Several novel putative autoimmune susceptibility loci have recently been identified with association with multiple autoimmune diseases. These include the IL2/21 region on chromosome 4q2312, 13 and the genes encoding IL7R,14, 15, 16CTLA4,17AFF314 and CD226.18 We hypothesise that these genes may also confer susceptibility to JIA and, therefore, the aim of this study was to determine whether single-nucleotide polymorphisms (SNPs) within these genes are also associated with susceptibility to JIA.
###end p 7
###begin title 8
Results and discussion
###end title 8
###begin p 9
###xml 159 166 159 166 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 241 245 241 245 <italic>AFF3</italic>
###xml 252 259 252 259 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 380 382 380 382 <xref ref-type="other" rid="bib19">19</xref>
###xml 380 382 380 382 <sup><xref ref-type="other" rid="bib19">19</xref></sup>
###xml 419 421 419 421 <xref ref-type="other" rid="bib20">20</xref>
###xml 419 421 419 421 <sup><xref ref-type="other" rid="bib20">20</xref></sup>
###xml 447 448 447 448 <italic>r</italic>
###xml 448 449 448 449 <sup>2</sup>
###xml 492 494 492 494 <xref ref-type="other" rid="bib14">14</xref>
###xml 492 494 492 494 <sup><xref ref-type="other" rid="bib14">14</xref></sup>
In this study, using a strategy of examining previously associated autoimmune loci in JIA, we have identified association of two loci with JIA susceptibility (Table 1). First, we show association of a SNP (rs1160542) in the 5' region of the AFF3 gene (Table 1), a gene that is preferentially expressed in lymphoid cells and has a potential regulatory role in lymphoid development.19 This SNP has been associated with RA20 and a perfect proxy SNP (r2=1), rs9653442 has been associated with T1D14 with similar odds ratio and allele frequencies to that observed in this study of JIA.
###end p 9
###begin p 10
###xml 76 79 76 79 <italic>IL2</italic>
###xml 80 84 80 84 <italic>IL21</italic>
###xml 182 189 182 189 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 191 193 191 193 <xref ref-type="other" rid="bib12">12</xref>
###xml 195 197 195 197 <xref ref-type="other" rid="bib13">13</xref>
###xml 191 197 191 197 <sup><xref ref-type="other" rid="bib12">12</xref>, <xref ref-type="other" rid="bib13">13</xref></sup>
###xml 241 245 241 245 <italic>IL21</italic>
###xml 339 347 339 347 <italic>KIAA1109</italic>
###xml 349 353 349 353 <italic>TENR</italic>
###xml 355 358 355 358 <italic>IL2</italic>
###xml 363 367 363 367 <italic>IL21</italic>
###xml 513 520 513 520 <italic>IL2_IL2</italic>
###xml 552 554 552 554 <xref ref-type="other" rid="bib21">21</xref>
###xml 552 554 552 554 <sup><xref ref-type="other" rid="bib21">21</xref></sup>
###xml 714 715 714 715 <italic>P</italic>
###xml 722 724 722 724 <sup>&#8722;5</sup>
###xml 786 787 786 787 <italic>P</italic>
###xml 877 882 877 882 <italic>IL2RA</italic>
###xml 896 897 896 897 <xref ref-type="other" rid="bib6">6</xref>
###xml 896 897 896 897 <sup><xref ref-type="other" rid="bib6">6</xref></sup>
Second, we found strong association of a SNP (rs6822844) mapping within the IL2-IL21 locus on chromosome 4q27, which has previously been associated with RA, T1D and coeliac disease (Table 1).12, 13 The SNP lies approximately 24 kb 5' of the IL21 gene. The SNP lies within a block of high linkage disequilibrium, which contains four genes, KIAA1109, TENR, IL2 and IL21. As for the other diseases, it is the common allele, which predisposes to JIA. This association confirms a recently published association of the IL2_IL2 region with JIA susceptibility.21 We performed a meta-analysis of the two studies, which yielded highly significant evidence for association (odds ratio 0.77 95% confidence interval 0.69-0.87, P=1 x 10-5) with no evidence for heterogeneity between the two cohorts (P=0.81). This finding is interesting in light of the previous confirmed association of the IL2RA gene with JIA6 and may suggest that the IL2 pathway is particularly important in JIA susceptibility.
###end p 10
###begin p 11
###xml 57 61 57 61 <italic>IL7R</italic>
###xml 77 84 77 84 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 149 151 149 151 <xref ref-type="other" rid="bib14">14</xref>
###xml 149 151 149 151 <sup><xref ref-type="other" rid="bib14">14</xref></sup>
###xml 174 176 174 176 <xref ref-type="other" rid="bib15">15</xref>
###xml 178 180 178 180 <xref ref-type="other" rid="bib16">16</xref>
###xml 174 180 174 180 <sup><xref ref-type="other" rid="bib15">15</xref>, <xref ref-type="other" rid="bib16">16</xref></sup>
###xml 392 413 392 413 <xref ref-type="other" rid="sup1">Supplementary Table 2</xref>
###xml 607 611 607 611 <italic>IL7R</italic>
###xml 742 744 742 744 <xref ref-type="other" rid="bib15">15</xref>
###xml 742 744 742 744 <sup><xref ref-type="other" rid="bib15">15</xref></sup>
We found a weak trend toward association of a SNP in the IL7R gene with JIA (Table 1), in line with the previous association of this SNP with RA, T1D14 and multiple sclerosis15, 16 the common allele of the SNP was increased in cases compared with controls, although this did not achieve statistical significance. However, this study was under-powered with only 18% power to detect an effect (Supplementary Table 2). Therefore, additional independent studies and meta-analyses of this SNP will be required to confirm it as associated with JIA susceptibility. The SNP is a non-synonymous SNP within exon 6 of IL7R and has a functional effect on gene expression, resulting in altered ratios of soluble and membrane-bound isoforms of the protein.15
###end p 11
###begin p 12
###xml 16 21 16 21 <italic>CTLA4</italic>
###xml 89 91 89 91 <xref ref-type="other" rid="bib17">17</xref>
###xml 89 91 89 91 <sup><xref ref-type="other" rid="bib17">17</xref></sup>
###xml 154 156 154 156 <xref ref-type="other" rid="bib22">22</xref>
###xml 158 160 158 160 <xref ref-type="other" rid="bib23">23</xref>
###xml 154 160 154 160 <sup><xref ref-type="other" rid="bib22">22</xref>, <xref ref-type="other" rid="bib23">23</xref></sup>
###xml 328 338 328 338 <italic>CTLA4 CT60</italic>
###xml 374 381 374 381 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 444 465 444 465 <xref ref-type="other" rid="sup1">Supplementary Table 2</xref>
###xml 595 597 595 597 <xref ref-type="other" rid="bib23">23</xref>
###xml 595 597 595 597 <sup><xref ref-type="other" rid="bib23">23</xref></sup>
###xml 845 846 845 846 <italic>P</italic>
###xml 935 936 935 936 <italic>P</italic>
###xml 1072 1077 1072 1077 <italic>CTLA4</italic>
###xml 1253 1255 1253 1255 <xref ref-type="other" rid="bib17">17</xref>
###xml 1253 1255 1253 1255 <sup><xref ref-type="other" rid="bib17">17</xref></sup>
###xml 1496 1498 1496 1498 <xref ref-type="other" rid="bib17">17</xref>
###xml 1496 1498 1496 1498 <sup><xref ref-type="other" rid="bib17">17</xref></sup>
SNPs within the CTLA4 gene, previously associated with T1D and autoimmune thyroid disease17 have previously been examined in JIA with conflicting results.22, 23 This may reflect true genetic heterogeneity at this locus or may be due to the modest sample sizes used in previous investigations. We found a weak association of the CTLA4 CT60 SNP (rs3087243) with UK JIA cases (Table 1), although this study only had 53% power to detect an effect (Supplementary Table 2). However, no evidence for association of this SNP with JIA was detected in a recent large study of US JIA families and controls.23 We used the Cochran-Mantel-Haenszel test to perform a meta-analysis combining data from this study and the Prahalad study; this yielded weak but statistically significant evidence for association (odds ratio 0.92 95% confidence interval 0.84-1.0, P=0.05) with no evidence for heterogeneity (by Breslow-Day test) between the two cohorts (P=0.44). Further analysis of this SNP in independent data sets followed by meta-analysis will be essential to robustly determine whether CTLA4 represents a JIA susceptibility locus. It is obviously a good candidate as an autoimmune susceptibility locus because of its role as a negative regulator of T-cell activation.17 Furthermore, the CT60 SNP is found within the 3' untranslated region, in which the G allele is associated with susceptibility to several autoimmune diseases and also has a functional effect of lower mRNA levels of the soluble CTLA4 isoform.17
###end p 12
###begin p 13
###xml 58 63 58 63 <italic>CD226</italic>
###xml 213 215 213 215 <xref ref-type="other" rid="bib18">18</xref>
###xml 213 215 213 215 <sup><xref ref-type="other" rid="bib18">18</xref></sup>
###xml 300 307 300 307 <xref rid="tbl1" ref-type="table">Table 1</xref>
###xml 362 383 362 383 <xref ref-type="other" rid="sup1">Supplementary Table 2</xref>
Finally, a non-synonymous SNP, rs763361, in exon 7 of the CD226 gene has recently been associated with multiple autoimmune diseases including T1D, multiple sclerosis and possibly autoimmune thyroid disease and RA.18 In our total JIA analysis, we found no significant association of the SNP with JIA (Table 1). However, we only had 24% power to detect an effect (Supplementary Table 2).
###end p 13
###begin p 14
###xml 0 8 0 8 <xref ref-type="fig" rid="fig1">Figure 1</xref>
###xml 304 309 304 309 <italic>CTLA4</italic>
###xml 314 318 314 318 <italic>IL7R</italic>
###xml 418 439 418 439 <xref ref-type="other" rid="sup1">Supplementary Table 2</xref>
###xml 585 591 585 591 <italic>PTPN22</italic>
###xml 732 734 732 734 <xref ref-type="other" rid="bib24">24</xref>
###xml 736 738 736 738 <xref ref-type="other" rid="bib25">25</xref>
###xml 732 738 732 738 <sup><xref ref-type="other" rid="bib24">24</xref>, <xref ref-type="other" rid="bib25">25</xref></sup>
###xml 817 822 817 822 <italic>IL2RA</italic>
###xml 906 908 906 908 <xref ref-type="other" rid="bib26">26</xref>
###xml 910 912 910 912 <xref ref-type="other" rid="bib27">27</xref>
###xml 906 912 906 912 <sup><xref ref-type="other" rid="bib26">26</xref>, <xref ref-type="other" rid="bib27">27</xref></sup>
Figure 1 shows a comparison between the association analysis results in T1D, RA, multiple sclerosis and JIA. For all the SNPs tested, the same allele was associated with JIA as was associated with the other autoimmune diseases and effect sizes are similar. Hence, the failure to confirm association with CTLA4 and IL7R at the corrected threshold could be due to a lack of statistical power (53 and 18%, respectively) (Supplementary Table 2). It has not always been the case for the overlapping autoimmune disease susceptibility loci, that the same allele is associated. For example in PTPN22, the minor allele of the R620W SNP is associated with greater risk of developing RA, JIA, T1D and SLE but is protective for Crohn's disease.24, 25 There is also emerging data suggesting that one of the associated SNPs at the IL2RA locus confers differing risk and protective effects for T1D and multiple sclerosis.26, 27
###end p 14
###begin p 15
###xml 150 171 150 171 <xref ref-type="other" rid="sup1">Supplementary Table 1</xref>
###xml 173 175 173 175 <xref ref-type="other" rid="bib28">28</xref>
###xml 173 175 173 175 <sup><xref ref-type="other" rid="bib28">28</xref></sup>
###xml 480 481 478 479 <sup>2</sup>
###xml 543 544 541 542 <italic>P</italic>
###xml 676 677 674 675 <italic>P</italic>
JIA is a phenotypically heterogeneous disease and can be classified into more clinically homogeneous diseases using the ILAR classification criteria (Supplementary Table 1).28 However, comparing each of the ILAR subtypes separately against controls would result in a large number of hypothesis tests. Therefore, we first examined whether there was evidence of a difference in allele frequencies between the seven ILAR subtypes. Differences between subtypes were assessed using chi2 tests on the 7 x 2 tables. Only when a difference was found (P<0.05) were separate odds ratios and 95% confidence intervals calculated for the subgroups. In all cases, this was not significant (P>0.05) (data not shown). Therefore, further stratification by ILAR subtype was not performed. Larger sample sizes will be required to fully examine subgroup differences.
###end p 15
###begin p 16
###xml 161 165 161 165 <italic>AFF3</italic>
###xml 174 182 174 182 <italic>IL2/IL21</italic>
In conclusion, adopting the strategy of targeting loci with previous evidence for association in multiple autoimmune diseases has identified two novel JIA loci, AFF3 and the IL2/IL21 locus.
###end p 16
###begin title 17
Conflict of interest
###end title 17
###begin p 18
The authors declare no conflict of interest.
###end p 18
###begin title 19
Supplementary Material
###end title 19
###begin title 20
Supplementary Tables 1 and 2
###end title 20
###begin p 21
This work was supported by the Arthritis Research Campaign: arc grant reference no: 17552. We thank David Strachan for facilitating access to the 1958 birth cohort. We acknowledge use of genotype data from the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02.
###end p 21
###begin p 22
###xml 0 25 0 25 <xref ref-type="other" rid="sup1">Supplementary Information</xref>
Supplementary Information accompanies the paper on Genes and Immunity website ()
###end p 22
###begin title 23
Appendix
###end title 23
###begin p 24
###xml 0 45 0 45 <italic>Childhood Arthritis Prospective Study (CAPS):</italic>
Childhood Arthritis Prospective Study (CAPS): Arc Epidemiology Unit, University of Manchester-Kimme Hyrich, Mark Lay, Sham Lal, Paul Gilbert, Peter Ward; Alderhey-Eileen Baildam, Carol Lydon, Lynsey Brown; Glasgow-Joyce Davidson, Janet Gardner-Medwin, Vicki Price, Jane Sim, Maureen Todd; Great Ormond Street-Lucy Wedderburn, Alexandra Meijer, Julie Jones; Newcastle-Helen Foster, Mark Friswell, Michael Eltringham; Manchester-Alice Chieng, Joanne Buckley; Other-Tauny Southwood
###end p 24
###begin p 25
###xml 0 17 0 17 <italic>UKRAG Consortium:</italic>
###xml 42 43 42 43 <sup>1</sup>
###xml 79 86 <span type="species:ncbi:9581">Gibbons</span>
UKRAG Consortium: University of Manchester1: Stephen Eyre, Anne Hinks, Laura J Gibbons, John Bowes, Edward Flynn, Paul Martin, Xiayi Ke, Rachelle Donn, Wendy Thomson, Anne Barton, Jane Worthington
###end p 25
###begin p 26
###xml 19 20 19 20 <sup>2</sup>
University of Leeds2: YEAR Consortiumdagger, Stephen Martin, James I Robinson, Ann W Morgan, Paul Emery
###end p 26
###begin p 27
###xml 23 24 23 24 <sup>3</sup>
University of Sheffield3: Anthony G Wilson
###end p 27
###begin p 28
###xml 20 21 20 21 <sup>4</sup>
University of London4: Sophia Steer
###end p 28
###begin p 29
###xml 22 23 22 23 <sup>5</sup>
University of Aberdeen5: Lynne Hocking, David M Reid
###end p 29
###begin p 30
###xml 20 21 20 21 <sup>6</sup>
University of Oxford6: Pille Harrison, Paul Wordsworth
###end p 30
###begin p 31
###xml 0 1 0 1 <sup>1</sup>
1arc-Epidemiology Unit, Stopford Building, The University of Manchester, Manchester, UK
###end p 31
###begin p 32
###xml 0 1 0 1 <sup>2</sup>
2Leeds Institute of Molecular Medicine, Section of Musculoskeletal Disease, University of Leeds, Leeds LS9 7TF, UK
###end p 32
###begin p 33
###xml 0 1 0 1 <sup>3</sup>
3School of Medicine & Biomedical Sciences, The University of Sheffield, Sheffield S10 2JF, UK
###end p 33
###begin p 34
###xml 0 1 0 1 <sup>4</sup>
4Clinical and Academic Rheumatology, Kings College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK
###end p 34
###begin p 35
###xml 0 1 0 1 <sup>5</sup>
5Bone Research Group, Department of Medicine & Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
###end p 35
###begin p 36
###xml 0 1 0 1 <sup>6</sup>
6University of Oxford Institute of Musculoskeletal Sciences, Botnar Research Centre, Oxford OX3 7LD, UK
###end p 36
###begin p 37
###xml 0 16 0 16 <italic>YEAR Consortium:</italic>
###xml 53 54 53 54 <sup>1</sup>
###xml 81 82 81 82 <sup>1</sup>
###xml 97 98 97 98 <sup>2</sup>
###xml 115 116 115 116 <sup>1</sup>
###xml 138 139 138 139 <sup>1</sup>
###xml 160 161 160 161 <sup>1</sup>
###xml 178 179 178 179 <sup>1</sup>
###xml 208 209 208 209 <sup>3</sup>
###xml 227 230 227 230 <sup>2,3</sup>
###xml 248 249 248 249 <sup>4</sup>
###xml 267 268 267 268 <sup>5</sup>
###xml 290 291 290 291 <sup>6</sup>
###xml 310 311 310 311 <sup>6</sup>
###xml 332 333 332 333 <sup>7</sup>
###xml 349 350 349 350 <sup>8</sup>
###xml 368 369 368 369 <sup>9</sup>
###xml 387 388 387 388 <sup>9</sup>
###xml 405 406 405 406 <sup>1</sup>
###xml 424 425 424 425 <sup>2</sup>
###xml 441 442 441 442 <sup>1</sup>
###xml 459 460 459 460 <sup>9</sup>
###xml 483 485 483 485 <sup>10</sup>
###xml 501 502 501 502 <sup>1</sup>
###xml 516 517 516 517 <sup>1</sup>
###xml 519 523 519 523 <italic>SpRs</italic>
###xml 544 545 544 545 <sup>1</sup>
###xml 560 561 560 561 <sup>1</sup>
###xml 563 570 563 570 <italic>Nurses&#8212;</italic>
###xml 582 583 582 583 <sup>1</sup>
###xml 601 602 601 602 <sup>1</sup>
###xml 617 618 617 618 <sup>1</sup>
###xml 634 635 634 635 <sup>1</sup>
###xml 653 654 653 654 <sup>3</sup>
###xml 671 672 671 672 <sup>4</sup>
###xml 688 689 688 689 <sup>4</sup>
###xml 700 701 700 701 <sup>2</sup>
###xml 714 715 714 715 <sup>2</sup>
###xml 735 736 735 736 <sup>1</sup>
###xml 753 754 753 754 <sup>1</sup>
###xml 768 770 768 770 <sup>10</sup>
###xml 784 786 784 786 <sup>10</sup>
###xml 799 800 799 800 <sup>1</sup>
###xml 814 815 814 815 <sup>1</sup>
###xml 827 828 827 828 <sup>6</sup>
###xml 841 842 841 842 <sup>7</sup>
###xml 859 860 859 860 <sup>6</sup>
###xml 862 871 862 871 <italic>Lab Staff</italic>
###xml 888 889 888 889 <sup>1</sup>
###xml 904 905 904 905 <sup>1</sup>
###xml 926 927 926 927 <sup>1</sup>
###xml 945 946 945 946 <sup>1</sup>
###xml 964 965 964 965 <sup>1</sup>
YEAR Consortium: Management Team-Professor Paul Emery1, Professor Philip Conaghan1, Dr Mark Quinn2, Dr Ann W Morgan1, Dr Anne-Maree Keenan1, Dr Elizabeth Hensor1, Julie Kitcheman1. Consultants-Dr Andrew Gough3, Dr Michael Green2,3, Dr Richard Reece4, Dr Lesley Hordon5, Dr Philip Helliwell16, Dr Richard Melsom6, Dr Sheelagh Doherty7, Dr Ade Adebajo8, Dr Andrew Harvey9, Dr Steve Jarrett9, Dr Gareth Huson1, Dr Amanda Isdale2, Dr Mike Martin1, Dr Zunaid Karim9, Prof Dennis McGonag1e10, Dr Colin Pease1, Dr Sally Cox1. SpRs-Dr Victoria Bejarano1, Dr Jackie Nam1. Nurses-Claire Brown1, Christine Thomas1, David Pickles1, Alison Hammond1, Beverley Neville3, Alan Fairclough4, Caroline Nunns4, Anne Gill2, Julie Green2, Belinda Rhys-Evans1, Barbara Padwell1, Julie Madden10, Lynda Taylor10, Sally Smith1, Heather King1, Jill Firth6, Jayne Heard7, Linda Sigsworth6. Lab Staff-Diane Corscadden1, Karen Henshaw1, Lubna-Haroon Rashid1, Stephen G Martin1, James I Robinson1
###end p 37
###begin p 38
###xml 0 1 0 1 <sup>1</sup>
1Section of Musculoskeletal Disease, LIMM, Leeds, UK
###end p 38
###begin p 39
###xml 0 1 0 1 <sup>2</sup>
2York District Hospital, York, UK
###end p 39
###begin p 40
###xml 0 1 0 1 <sup>3</sup>
3Harrogate District Hospital, Harrogate, UK
###end p 40
###begin p 41
###xml 0 1 0 1 <sup>4</sup>
4Huddersfield Royal Infirmary, Huddersfield, UK
###end p 41
###begin p 42
###xml 0 1 0 1 <sup>5</sup>
5Dewsbury District and General Hospital, Dewsbury, UK
###end p 42
###begin p 43
###xml 0 1 0 1 <sup>6</sup>
6St Luke's Hospital, Bradford, UK
###end p 43
###begin p 44
###xml 0 1 0 1 <sup>7</sup>
7Hull Royal Infirmary, Hull, UK
###end p 44
###begin p 45
###xml 0 1 0 1 <sup>8</sup>
8Barnsley District General Hospital, Barnsley, UK
###end p 45
###begin p 46
###xml 0 1 0 1 <sup>9</sup>
9Pinderfields General Hospital, Wakefield, UK
###end p 46
###begin p 47
###xml 0 2 0 2 <sup>10</sup>
10Calderdale Royal Hospital, Halifax, UK
###end p 47
###begin p 48
###xml 0 77 0 77 <italic>British Society of Paediatric and Adolescent Rheumatology (BSPAR) study group</italic>
British Society of Paediatric and Adolescent Rheumatology (BSPAR) study group: M Abinum, MD, M Becker, MD, A Bell, MD, A Craft, MD, E Crawley, MD, J David, MD, H Foster, MD, J Gardener-Medwin, MD, J Griffin, MD, A Hall, MD, M Hall, MD, A Herrick, MD, P Hollingworth, MD, L Holt, MD, S Jones, MD, G Pountain, MD, C Ryder, MD, T Southwood, MD, I Stewart, MD, H Venning, L Wedderburn, MD, P Woo, MD and S Wyatt, MD.
###end p 48
###begin article-title 49
Autoimmune diseases: insights from genome-wide association studies
###end article-title 49
###begin article-title 50
Detecting shared pathogenesis from the shared genetics of immune-related diseases
###end article-title 50
###begin article-title 51
Genetic analysis of autoimmune disease
###end article-title 51
###begin article-title 52
Juvenile idiopathic arthritis
###end article-title 52
###begin article-title 53
The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis
###end article-title 53
###begin article-title 54
Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis
###end article-title 54
###begin article-title 55
Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls
###end article-title 55
###begin article-title 56
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes
###end article-title 56
###begin article-title 57
Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs
###end article-title 57
###begin article-title 58
Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus
###end article-title 58
###begin article-title 59
Overlap of disease susceptibility loci for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)
###end article-title 59
###begin article-title 60
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21
###end article-title 60
###begin article-title 61
Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases
###end article-title 61
###begin article-title 62
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
###end article-title 62
###begin article-title 63
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis
###end article-title 63
###begin article-title 64
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
###end article-title 64
###begin article-title 65
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
###end article-title 65
###begin article-title 66
CD226 Gly307Ser association with multiple autoimmune diseases
###end article-title 66
###begin article-title 67
LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias
###end article-title 67
###begin article-title 68
Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes
###end article-title 68
###begin article-title 69
Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis
###end article-title 69
###begin article-title 70
The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland
###end article-title 70
###begin article-title 71
Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis
###end article-title 71
###begin article-title 72
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
###end article-title 72
###begin article-title 73
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
###end article-title 73
###begin article-title 74
IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production
###end article-title 74
###begin article-title 75
IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D)
###end article-title 75
###begin article-title 76
International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001
###end article-title 76
###begin article-title 77
Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome
###end article-title 77
###begin article-title 78
Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the childhood arthritis prospective study
###end article-title 78
###begin article-title 79
Rheumatoid arthritis association at 6q23
###end article-title 79
###begin article-title 80
PLINK: a tool set for whole-genome association and population-based linkage analyses
###end article-title 80
###begin p 81
###xml 346 348 346 348 <xref ref-type="other" rid="bib12">12</xref>
###xml 350 352 350 352 <xref ref-type="other" rid="bib14">14</xref>
###xml 354 356 354 356 <xref ref-type="other" rid="bib16">16</xref>
###xml 358 360 358 360 <xref ref-type="other" rid="bib17">17</xref>
###xml 362 364 362 364 <xref ref-type="other" rid="bib18">18</xref>
###xml 346 364 346 364 <sup><xref ref-type="other" rid="bib12">12</xref>, <xref ref-type="other" rid="bib14">14</xref>, <xref ref-type="other" rid="bib16">16</xref>, <xref ref-type="other" rid="bib17">17</xref>, <xref ref-type="other" rid="bib18">18</xref></sup>
Plot of odds ratios for minor allele for SNPs previously associated with autoimmune disease, comparison with JIA. Plots of odds ratios and 95% confidence intervals for the association analysis of all SNPs, results in T1D (black dots and lines), in RA (blue dots and lines), in JIA (red dots and lines) and in MS (green dots and lines). References12, 14, 16, 17, 18 and Barton (2009) submitted.
###end p 81
###begin p 82
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Association analysis results for those SNPs associated with multiple autoimmune diseases in a cohort of patients with JIA
###end p 82
###begin p 83
###xml 37 38 37 38 <italic>P</italic>
Abbreviations: Chr, chromosome; HWE, P-value statistic for Hardy-Weinberg equilibrium test; JIA, juvenile idiopathic arthritis; MAF, minor allele frequency; SNP, single-nucleotide polymorphism.
###end p 83
###begin p 84
###xml 102 103 102 103 <italic>P</italic>
A Bonferroni correction of five was applied to correct for the number of loci studied, resulting in a P-value threshold of 0.01 for claims of significance.
###end p 84
###begin p 85
Genotyping was performed using the Sequenom iPLEX platform. A 90% sample quality control rate and 90% SNP genotyping success rate was imposed on the analysis.
###end p 85
###begin p 86
The gene name refers to the nearest gene in the region although SNPs are not necessarily intra-genic.
###end p 86
###begin p 87
###xml 27 28 27 28 <italic>n</italic>
###xml 154 155 154 155 <italic>n</italic>
###xml 220 221 220 221 <italic>n</italic>
###xml 248 250 248 250 <xref ref-type="other" rid="bib29">29</xref>
###xml 248 250 248 250 <sup><xref ref-type="other" rid="bib29">29</xref></sup>
###xml 432 433 432 433 <italic>n</italic>
###xml 439 441 439 441 <xref ref-type="other" rid="bib30">30</xref>
###xml 439 441 439 441 <sup><xref ref-type="other" rid="bib30">30</xref></sup>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
UK Caucasian JIA patients (n=1054) from three sources. The British Society for Paediatric and Adolescent Rheumatology (BSPAR) National Repository of JIA (n=654), a cohort of UK Caucasian patients with long-standing JIA (n=201), described previously29 and a third cohort collected as part of the Childhood Arthritis prospective Study (CAPS), a prospective inception cohort study of JIA cases from five centres across United Kingdom (n=199).30
###end p 87
###begin p 88
###xml 116 118 116 118 <xref ref-type="other" rid="bib31">31</xref>
###xml 116 118 116 118 <sup><xref ref-type="other" rid="bib31">31</xref></sup>
Healthy Caucasian control DNA samples were available from five centres in the United Kingdom as described previously31: Manchester, 924 controls (including 228 in 1958 birth cohort controls); Sheffield, 995 controls; Leeds 532 controls; Aberdeen 862 controls; Oxford 536 controls, total control sample size=3531.
###end p 88
###begin p 89
###xml 141 143 141 143 <xref ref-type="other" rid="bib32">32</xref>
###xml 141 143 141 143 <sup><xref ref-type="other" rid="bib32">32</xref></sup>
Genotype and allele frequencies were compared between cases with JIA and controls using the Cochrane-Armitage trend test implemented in PLINK32 and allelic odds ratios (ORs) and their 95% confidence intervals (CIs) calculated.
###end p 89

